| Literature DB >> 26080693 |
Ian Baker1,2, Steve N Fiering2,3, Karl E Griswold1,3, P Jack Hoopes1,2,3, Katerina Kekalo1, Christian Ndong1, Keith Paulsen1,2, Alicea A Petryk2, Brian Pogue1,2,3, Fridon Shubitidze1, John Weaver1,2,3.
Abstract
The Dartmouth Center for Cancer Nanotechnology Excellence - one of nine funded by the National Cancer Institute as part of the Alliance for Nanotechnology in Cancer - focuses on the use of magnetic nanoparticles for cancer diagnostics and hyperthermia therapy. It brings together a diverse team of engineers and biomedical researchers with expertise in nanomaterials, molecular targeting, advanced biomedical imaging and translational in vivo studies. The goal of successfully treating cancer is being approached by developing nanoparticles, conjugating them with Fabs, hyperthermia treatment, immunotherapy and sensing treatment response.Entities:
Keywords: immunotherapy; magnetic hyperthermia; magnetic nanoparticles
Mesh:
Year: 2015 PMID: 26080693 PMCID: PMC4493741 DOI: 10.2217/nnm.15.64
Source DB: PubMed Journal: Nanomedicine (Lond) ISSN: 1743-5889 Impact factor: 5.307